CYP2S1: A short review

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 62-69

  Saarikoski, Sirkku T ^a,b   Rivera, Steven P ^c   Hankinson, Oliver ^c   Husgafvel Pursiainen, Kirsti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CYP2S1; Cytochrome P450; Dioxin; Xenobiotic metabolism

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; COAL TAR; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 CYP 2A13; CYTOCHROME P450 CYP 2F1; CYTOCHROME P450 CYP 2S1; DIOXIN; NAPHTHALENE; POLYCYCLIC AROMATIC HYDROCARBON; RETINOIC ACID; TOBACCO SMOKE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BIOTRANSFORMATION; CHROMOSOME 19Q; CONFERENCE PAPER; EMBRYO DEVELOPMENT; ENZYME INDUCTION; ENZYME METABOLISM; ENZYME REGULATION; EPITHELIUM CELL; GASTROINTESTINAL TRACT; GENE CLUSTER; GENE LOCATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN; TISSUE DISTRIBUTION; ULTRAVIOLET RADIATION;

EID: 24644473254     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2004.12.027     Document Type: Conference Paper

References (58)

1. S. Arpiainen, F. Raffalli-Mathieu, M.A. Lang, O. Pelkonen, and J. Hakkola Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway Mol. Pharmacol. 67 2005 1325 1333
2. A. Asikainen, J. Tarhanen, A. Poso, M. Pasanen, E. Alhava, and R.O. Juvonen Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes Toxicol. In Vitro 17 2003 449 455
3. H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic polymorphisms of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol., Biomarkers Prev. 9 2000 3 28
4. H. Chen, W.N. Howald, and M.R. Juchau Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P450 cytochromes Drug Metab. Dispos. 28 2000 315 322
5. D. Choudhary, I. Jansson, JB. Schenkman, M. Sarfarazi, and I. Stoilov Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues Arch. Biochem. Biophys. 414 2003 91 100
6. D. Choudhary, I. Jansson, I. Stoilov, M. Sarfarazi, and J.B. Schenkman Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues Arch. Biochem. Biophys. 436 2005 50 61
7. A. Dey, J.E. Jones, and D.W. Nebert Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization Biochem. Pharmacol. 58 1999 525 537
8. X. Ding, and L.S. Kaminsky Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 43 2003 149 173
9. L. Du, S.M. Hoffman, and D.S. Keeney Epidermal CYP2 family cytochromes P450 Toxicol. Appl. Pharmacol. 195 2004 278 287
10. J. Gilmore, F. Rotondo, A.M. Pelletier, J. LaMarre, M. Alaoui-Jamali, and G.M. Kirby Identification of a 43-kDa protein in human liver cytosol that binds to the 3′-untranslated region of CYP2A6 mRNA Biochem. Pharmacol. 62 2001 669 678
11. M.S. Gokhale, T.E. Bunton, J. Zurlo, and J.D. Yager Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices Xenobiotica 27 1997 341 355
12. O. Hankinson The aryl hydrocarbon receptor complex Annu. Rev. Pharmacol. Toxicol. 35 1995 307 340
13. S.M. Hoffman, D.R. Nelson, and D.S. Keeney Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19 Pharmacogenetics 11 2001 687 698
14. R. Holmila, S.T. Saarikoski, T. Suitiala, and K. Husgafvel-Pursiainen Application of capillary electrophoresis SSCP for analysis of CYP2S1 genetic polymorphisms Toxicol. Appl. Pharmacol. 197 2004 255
15. J. Hukkanen, J. Hakkola, S. Anttila, R. Piipari, A. Karjalainen, O. Pelkonen, and H. Raunio Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes Mol. Carcinog. 20 1997 224 230
16. J. Hukkanen, O. Pelkonen, J. Hakkola, and H. Raunio Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung Crit. Rev. Toxicol. 32 2002 391 411
17. M. Ingelman-Sundberg Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms Naunyn-Schmiedeberg's Arch. Pharmacol. 369 2004 89 104
18. M. Ingelman-Sundberg, M. Oscarson, and R.A. McLellan Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment Trends Pharmacol. Sci. 20 1999 342 349
19. M. Karlgren, S. Miura, and M. Ingelman-Sundberg Novel extrahepatic cytochrome P450s Toxicol Appl Pharmacol. 207 2005 57 61
20. S.K. Katiyar, M.S. Matsui, and H. Mukhtar Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1 J. Invest. Dermatol. 114 2000 328 333
21. M. Kumarakulasingham, P.H. Rooney, S.R. Dundas, C. Telfer, W.T. Melvin, S. Curran, and G.I. Murray Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis Clin. Cancer Res. 11 10 2005 May 15 3758 3765
22. K. Kurose, M. Tohkin, and M. Fukuhara A novel positive regulatory element that enhances hamster CYP2A8 gene expression mediated by xenobiotic responsive element Mol. Pharmacol. 55 1999 279 287
23. T. Lang, K. Klein, J. Fischer, A.K. Nussler, P. Neuhaus, U. Hofmann, M. Eichelbaum, M. Schwab, and U.M. Zanger Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver Pharmacogenetics 11 2001 399 415
24. D.L. Lanza, E. Code, C.L. Crespi, F.J. Gonzalez, and G.S. Yost Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells Drug Metab. Dispos. 27 1999 798 803
25. D.F. Lewis 57 varieties: the human cytochromes P450 Pharmacogenomics 5 2004 305 318
26. J. Marill, N. Idres, C.C. Capron, E. Nguyen, and G.G. Chabot Retinoic acid metabolism and mechanism of action: a review Curr. Drug Metab. 4 2003 1 10
27. G.I. Murray The role of cytochrome P450 in tumour development and progression and its potential in therapy J. Pathol. 192 2000 419 426
28. L. Muskhelishvili, P.A. Thompson, D.F. Kusewitt, C. Wang, and F.F. Kadlubar In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues J. Histochem. Cytochem. 49 2001 229 236
29. K. Nagata, T. Matsunaga, J. Gillette, H.V. Gelboin, and F.J. Gonzalez Rat testosterone 7 alpha-hydroxylase. Isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene J. Biol. Chem. 262 1987 2787 2793
30. D.W. Nebert Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions Mol. Endocrinol. 5 1991 1203 1214
31. D.W. Nebert, and D.W. Russell Clinical importance of the cytochromes P450 Lancet 360 2002 1155 1162
32. D.W. Nebert, D.D. Petersen, and A.J. Fornace Jr. Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm Environ. Health Perspect. 88 1990 13 25
33. D.R. Nelson, D.C. Zeldin, S.M. Hoffman, L.J. Maltais, H.M. Wain, and D.W. Nebert Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants Pharmacogenetics 14 2004 1 18
34. M. Nishimura, H. Yaguti, H. Yoshitsugu, S. Naito, and T. Satoh Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR Yakugaku Zasshi 123 2003 369 375
35. T. Oyama, N. Kagawa, N. Kunugita, K. Kitagawa, M. Ogawa, T. Yamaguchi, R. Suzuki, T. Kinaga, Y. Yashima, S. Ozaki, T. Isse, Y.D. Kim, H. Kim, and T. Kawamoto Expression of cytochrome P450 in tumor tissues and its association with cancer development Front. Biosci. 9 2004 1967 1976
36. D.M. Otto, C.J. Henderson, D. Carrie, M. Davey, T.E. Gundersen, R. Blomhoff, R.H. Adams, C. Tickle, and C.R. Wolf Identification of novel roles of the cytochrome P450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis Mol. Cell. Biol. 23 2003 6103 6116
37. O. Pelkonen, and H. Raunio Metabolic activation of toxins: tissue-specific expression and metabolism in target organs Environ. Health Perspect. 105 1997 767 774
38. R. Preuss, J. Angerer, and H. Drexler Naphthalene-An environmental and occupational toxicant Int. Arch. Occup. Environ. Health 76 2003 556 576
39. H. Raunio, K. Husgafvel-Pursiainen, S. Anttila, E. Hietanen, A. Hirvonen, and O. Pelkonen Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-A review Gene 159 1995 113 121
40. H. Raunio, A. Rautio, H. Gullsten, and O. Pelkonen Polymorphisms of CYP2A6 and its practical consequences Br. J. Clin. Pharmacol. 52 2001 357 363
41. S.P. Rivera, S.T. Saarikoski, and O. Hankinson Identification of a novel dioxin-inducible cytochrome P450 Mol. Pharmacol. 61 2002 255 259
42. T. Rylander, E.P. Neve, M. Ingelman-Sundberg, and M. Oscarson Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1) Biochem. Biophys. Res. Commun. 281 2001 529 535
43. S.T. Saarikoski, K. Husgafvel-Pursiainen, A. Hirvonen, H. Vainio, F.J. Gonzalez, and S. Anttila Localization of CYP1A1 mRNA in human lung by in situ hybridization: comparison with immunohistochemical findings Int. J. Cancer 77 1998 33 39
44. S.T. Saarikoski, T. Suitiala, R. Holmila, O. Impivaara, J. Järvisalo, A. Hirvonen, and K. Husgafvel-Pursiainen Identification of genetic polymorphism of CYP2S1 in a Finnish Caucasian population Mutat. Res. 554 2004 267 277
45. S.T. Saarikoski, H. Wikman, G. Smith, H. Wolf, and K. Husgafvel-Pursiainen Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridisation and immunohistochemistry J. Histochem. Cytochem. 53 2005 549 556
46. C. Sachse, B. Brockmoller, S. Bauer, and I. Roots Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences Am. J. Hum. Genet. 60 1997 284 295
47. S. Saito, A. Iida, A. Sekine, S. Kawauchi, S. Higuchi, C. Ogawa, and Y. Nakamura Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population J. Hum. Genet. 48 2003 249 270
48. J.V. Schmidt, and C.A. Bradfield Ah receptor signaling pathways Annu. Rev. Cell Dev. Biol. 12 1996 55 89
49. T. Shimada, and Y. Fujii-Kuriyama Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1 Cancer Sci. 95 2004 1 6
50. G. Smith, C.R. Wolf, Y.Y. Deeni, R.S. Dawe, AT. Evans, M.M. Comrie, J. Ferguson, and S.H. Ibbotson Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases Lancet 361 2003 1336 1343
51. I. Stoilov Cytochrome P450s: coupling development and environment Trends Genet. 17 2001 629 632
52. I. Stoilov, I. Jansson, M. Sarfarazi, and J.B. Schenkman Roles of cytochrome p450 in development Drug Metab. Drug Interact. 18 2001 33 55
53. T. Su, Z. Bao, Q.Y. Zhang, T.J. Smith, J.Y. Hong, and X. Ding Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone Cancer Res. 60 2000 5074 5079
54. H.I. Swanson, and C.A. Bradfield The AH-receptor: genetics, structure and function Pharmacogenetics 3 1993 213 230
55. A. Tilloy-Ellul, F. Raffalli-Mathieu, and M.A. Lang Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA Biochem. J. 339 1999 695 703
56. S.L. Wang, Y.Y. He, and J.Y. Hong Human cytochrome 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine Drug Metab. Dispos. 33 2005 336 340
57. Y.D. Wei, U. Rannug, and A. Rannug UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan Chem. Biol. Interact. 118 1999 127 140
58. J.A. White, B. Beckett-Jones, Y.D. Guo, F.J. Dilworth, J. Bonasoro, G. Jones, and M. Petkovich cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 J. Biol. Chem. 272 1997 18538 18541